Attached files
| file | filename |
|---|---|
| 8-K - Vystar Corp | v180852_8k.htm |
| EX-10.1 - Vystar Corp | v180852_ex10-1.htm |
| EX-10.2 - Vystar Corp | v180852_ex10-2.htm |
VYSTAR®
CORPORATION APPOINTS JACK W. CALLICUTT AS CHIEF FINANCIAL OFFICER
Twenty
Years of Progressive Financial Management Adds Strength to Company
ATLANTA, GA – April 13, 2010 –
Vystar®
Corporation (OTCBB: VYST), the exclusive creator of Vytex® Natural
Rubber Latex (NRL), a patented, all-natural raw material that significantly
reduces antigenic proteins found in natural rubber latex, has appointed Jack W.
Callicutt as its new Chief Financial Officer. Mr. Callicutt replaces
Mrs. Linda Hammock, who was Vystar’s acting CFO through its development stage
and has now focused her attention on other development stage
companies.
Mr.
Callicutt, age 43, has over 20 years of private and public accounting and
financial management experience in startup and midsize companies in the
technology, biopharmaceutical and accounting/consulting industries. Prior to his
arrival at Vystar, Mr. Callicutt served as Chief Financial Officer at IVOX,
Inc., where he negotiated and secured $3.89 million in investment capital from a
strategic investor.
Previously,
Mr. Callicutt was Chief Financial Officer at Tikvah Therapeutics, a
clinical-stage biopharmaceutical company, where he was responsible for all
financial, risk management and administrative functions, including investor
relations. This followed his position as Chief Financial Officer at Corautus
Genetics, a publicly traded biopharmaceutical company. His accomplishments
included completing several private placements of common stock raising over $33
million and negotiating and closing a merger with VIA Pharmaceuticals, Inc., San
Francisco, CA.
Mr.
Callicutt began his career with Deloitte rising to the level of Senior Manager,
where he managed engagements for manufacturing, telecommunications and
technology companies. A Certified Public Accountant, he earned a BBA in
Accounting and Computer Information Systems from Delta State University in
Mississippi.
William
Doyle, the company’s President and Chief Executive Officer,
commented:
“Jack’s
experience in working at startups undergoing the transition from development
stage to revenues will serve our company well. He is a strong
addition to our management team and we expect to rely on his financial acumen as
we work to accelerate our growth strategy for Vystar.”
About
Vystar Corporation
Based in
Duluth, GA, Vystar Corporation (OTC BB: VYST.OB) is the exclusive creator of
Vytex Natural Rubber Latex (NRL), a patented, all-natural raw material that
significantly reduces antigenic proteins found in natural rubber latex and can
be used in over 40,000 products. Vystar is working with manufacturers across a
broad range of consumer and medical products to bring Vytex NRL to market in
adhesives, balloons, surgical and exam gloves, other medical devices and natural
rubber latex foam mattresses, pillows and sponges. For more
information, visit www.vytex.com.
Forward-looking
Statements
Certain
statements in this document are "forward-looking statements" within the meaning
of the Private Securities Litigation Reform Act. These statements are based on
management's current expectations and are subject to uncertainty and changes in
circumstances. Actual results may differ materially from those
included in these statements due to a variety of factors. More
information about these factors is contained in Vystar's filings with the
Securities and Exchange Commission.
Contact:
The
Investor Relations Group
11 Stone
St. 3rd Floor
New York,
NY
212-825-3210
IR: Adam
Holdsworth
or
PR: Laura
Colontrelle/Janet Vasquez